Castle Biosciences, Inc. Common Stock(CSTL)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$24.12
52-Week Range
$14.59 – $44.28
YTD
-37.42%
IV Rank (30D)
59.53
Straddle Price
$3.02
P/C Vol Ratio
0.25
Market Cap
$0.7B
Fair Value
-42.9% vs price
Confidence: 30% Alpha Score: 0.28

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.50%
Beta vs SPY1.00
Cost of Equity (CAPM)10.00% (VRP-adj)
WACC10.01%
Volatility Risk Premium+83.7pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-2.9%
DCF Horizon10 years explicit + fade
Free Cash Flow (TTM)$0.0B
Return on Equity (TTM)-2.8%
Book / Price68.6% — banking bias active (P/B is primary)
Gross Margin (TTM)77.9%
FCF Margin (TTM)1.3%
Debt / Equity0.02
Quality Score2/6 — normal (10y DCF)
SMA 50$21.79 (Market Anchor value)
SMA 20 / Bollinger Mid$21.05
Bollinger Width / SMA2065.5% (drives anchor stability)
Net Debt$-0.1B
Market Cap$1B
Peers used for multiples: CNC, HUM, PGNY, UNH (filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$13.88
Current Price
$24.30
Deviation
-42.9%
Forward-Return Rank SHORT gates ✓
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -3.9% -0.23 -0.93 19.3%
42d -6.3% -0.36 -0.93 19.3%
63d -6.2% -0.07 -0.93 19.3%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF $3.41 56%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 31.1× · 3 peers
Peer EV/EBITDA n/a 0% median 19.2× · 4 peers
Peer P/B $47.99 22% median 3.1× · 4 peers
Peer P/S $6.60 22% median 0.6× · 4 peers
Market Anchor (SMA50) $21.79 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-26 · updated 2026-06-26 20:59:30.580000
Info
Industry (SIC)
SERVICES-MEDICAL LABORATORIES (8071)
Exchange
XNAS
Market Cap
$0.7B

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dyspla…

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +2.97% 6
Feb -13.22% 6
Mar -0.48% 6
Apr -9.98% 6
May -3.65% 6
Jun +2.74% 6
Jul +9.28% 5
Aug +9.63% 5
Sep -9.43% 5
Oct +1.29% 5
Nov +5.72% 5
Dec -0.87% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $21.16
SMA 50: $21.78
SMA 200: $28.67
Current: $24.30
EMA 12: $21.81
EMA 26: $21.47
MACD: 0.3386 | Signal: 0.4169
BEARISH
ADX (14): 13.58
RANGE
+DI: 34.46
−DI: 16.13
Momentum Oscillators
RSI (14): 67.87
NEUTRAL
Stoch %K: 95.12
Stoch %D: 87.19
Williams %R: -0.95
Volume & Volatility
BB Upper: $23.14
BB Lower: $19.17
OVERBOUGHT
OBV: 8,475,944
Vol SMA 20: 380,966
Vol ROC: 385.02%
ATR: $1.03
True Range: $1.67
HV 20: 55.4%
HV 30: 53.8%
HV 60: 71.7%

Data Summary
Data Points: 500
Last Updated: 2026-06-26T21:15:22.669000
Date Range: 2024-06-28T00:00:00 – 2026-06-26T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
7 of 9 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-05 After-Close 19.16% 2.21% 0.12x Within
2024-11-04 After-Close 17.44% 13.45% 0.77x Within
2025-01-13 After-Close 8.32% 2.64% 0.32x Within
2025-02-27 After-Close 14.04% 14.24% 1.01x Exceeded
2025-05-05 After-Close 17.84% 12.94% 0.73x Within
2025-08-04 After-Close 17.70% 24.24% 1.37x Exceeded
2025-11-03 After-Close 17.41% 17.35% 1.00x Within
2026-02-26 After-Close 17.73% 6.37% 0.36x Within
2026-05-06 After-Close 24.89% 18.47% 0.74x Within
Options Activity
IV Rank (30D)
59.53
IV Rank (7D)
59.53
Avg IV
141.1%
Straddle (30D)
$3.02
Straddle (7D)
$3.02
P/C Volume
0.25
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.76
Correlation (SPY)
14.7%
0.02
Ann. Volatility
64.3%
SPY Volatility
12.5%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 29,373,250 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

183 filers27,325,280 shares$682.95M value93.03% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 2,199,829 $85.57M 12.53% 7.49% 2025-12-31
2 BlackRock, Inc. Custodian 2,982,946 $73.23M 10.72% 10.16% 2026-03-31
3 RTW INVESTMENTS, LP 2,758,335 $67.72M 9.92% 9.39% 2026-03-31
4 PRINCIPAL FINANCIAL GROUP INC 1,769,877 $43.45M 6.36% 6.03% 2026-03-31
5 Portolan Capital Management, LLC 1,350,283 $33.15M 4.85% 4.60% 2026-03-31
6 DIMENSIONAL FUND ADVISORS LP Custodian 1,039,761 $25.52M 3.74% 3.54% 2026-03-31
7 SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 940,685 $23.09M 3.38% 3.20% 2026-03-31
8 Allianz Asset Management GmbH 811,324 $19.92M 2.92% 2.76% 2026-03-31
9 STATE STREET CORP 769,079 $18.88M 2.76% 2.62% 2026-03-31
10 GEODE CAPITAL MANAGEMENT, LLC Custodian 728,100 $17.88M 2.62% 2.48% 2026-03-31
11 AIGH Capital Management LLC 590,601 $14.50M 2.12% 2.01% 2026-03-31
12 Qube Research & Technologies Ltd 559,583 $13.74M 2.01% 1.91% 2026-03-31
13 PALISADE CAPITAL MANAGEMENT, LP 535,884 $13.16M 1.93% 1.82% 2026-03-31
14 RENAISSANCE TECHNOLOGIES LLC 532,800 $13.08M 1.92% 1.81% 2026-03-31
15 Nuveen, LLC Custodian 522,127 $12.82M 1.88% 1.78% 2026-03-31
16 WASATCH ADVISORS LP 455,036 $11.17M 1.64% 1.55% 2026-03-31
17 EVENTIDE ASSET MANAGEMENT, LLC 386,425 $9.49M 1.39% 1.32% 2026-03-31
18 Connor, Clark & Lunn Investment Management Ltd. 377,082 $9.26M 1.36% 1.28% 2026-03-31
19 MILLENNIUM MANAGEMENT LLC Custodian 353,319 $8.67M 1.27% 1.20% 2026-03-31
20 GOLDMAN SACHS GROUP INC Custodian 341,171 $8.38M 1.23% 1.16% 2026-03-31
21 MORGAN STANLEY Custodian 203,577 $7.92M 1.16% 0.69% 2025-12-31
22 SCHRODER INVESTMENT MANAGEMENT GROUP 298,941 $7.04M 1.03% 1.02% 2026-03-31
23 NORTHERN TRUST CORP Custodian 273,101 $6.70M 0.98% 0.93% 2026-03-31
24 SILVERCREST ASSET MANAGEMENT GROUP LLC 268,535 $6.59M 0.97% 0.91% 2026-03-31
25 KORNITZER CAPITAL MANAGEMENT INC /KS 264,396 $6.49M 0.95% 0.90% 2026-03-31
5 filers$1.91M notional
# Filer Notional Value % of Total Period
1 CITADEL ADVISORS LLC Custodian $797.88K 41.67% 2026-03-31
2 JANE STREET GROUP, LLC Custodian $559.74K 29.23% 2026-03-31
3 IMC-Chicago, LLC Custodian $260.23K 13.59% 2026-03-31
4 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $228.31K 11.92% 2026-03-31
5 SIMPLEX TRADING, LLC Custodian $68.74K 3.59% 2026-03-31
2 filers$436.99K notional
# Filer Notional Value % of Total Period
1 CITADEL ADVISORS LLC Custodian $306.88K 70.22% 2026-03-31
2 GROUP ONE TRADING LLC Custodian $130.12K 29.78% 2026-03-31
Insider Activity
Latest: 2026-06-18
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-18 Kristen M Oelschlager Chief Operating Officer Sell (S) −8,587 $20.71 -$177.8K EDGAR
2026-06-17 DEREK J MAETZOLD Pres. & Chief Exec. Officer Mixed −3,622 $18.53 -$84.9K EDGAR
2026-06-03 DEREK J MAETZOLD Pres. & Chief Exec. Officer Mixed −3,622 $13.71 -$190.3K EDGAR
2026-06-01 DANIEL BRADBURY Director Grant (A) +11,766 RSU EDGAR
2026-06-01 Rodney Cotton Director Grant (A) +11,766 RSU EDGAR
2026-06-01 G Bradley Cole Director Grant (A) +11,766 RSU EDGAR
2026-06-01 Ellen Goldberg Director Grant (A) +11,766 RSU EDGAR
2026-06-01 Miles Harrison Director Grant (A) +11,766 RSU EDGAR
2026-06-01 Kim Caple Director Grant (A) +11,766 RSU EDGAR
2026-06-01 Tiffany Olson Director Grant (A) +11,766 RSU EDGAR
2026-05-27 Kim Caple Director Exer (M) +13,667 EDGAR
2026-05-27 Ellen Goldberg Director Exer (M) +13,667 EDGAR
2026-05-27 Tiffany Olson Director Exer (M) +13,667 EDGAR
2026-05-27 Miles Harrison Director Exer (M) +13,667 EDGAR
2026-05-27 DANIEL BRADBURY Director Exer (M) +13,667 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
25 insiders · @ $24.30
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Sofinnova HealthQuest Partners, L.P. 10%+ Owner 1,676,061 $40.73M $3.00M 1 2019-07-31
2 HealthQuest Venture Management, L.L.C. 10%+ Owner 1,533,577 $37.27M -$39.84M 6 2020-05-19
3 MGC Venture Partners 2013 GP, LLC 10%+ Owner 1,496,855 $36.37M $25.00M 1 2019-07-31
4 Garheng Kong 10%+ Owner 1,433,577 $34.84M -$25.87M 1 2020-05-14
5 DAVID S KABAKOFF Director 503,577 $12.24M -$63.36M 23 2021-06-21
6 Kristen M Oelschlager Chief Operating Officer 127,711 $3.10M -$4.11M 26 2026-06-18
7 Joseph C. III Cook Director 125,124 $3.04M -$47.87M 30 2021-03-22
8 MGC Venture Partners 2018 GP, LLC 10%+ Owner 115,300 $2.80M -$2.02M 1 2020-05-14
9 MGC VENTURE PARTNERS QP 2018, L.P. 10%+ Owner 115,300 $2.80M -$4.02M 1 2020-05-19
10 Tobin W Juvenal Chief Commercial Officer 100,265 $2.44M -$2.29M 26 2026-05-26
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-06-16
Last 30d: 2 filings · $912K notice value  ·  Last 90d: 3 filings · $1.2M notice value · 2 unique filers · 100% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.

Top 90-day filers: KRISTEN OELSCHLAGER (1, $618K) · Derek Maetzold (2, $563K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-06-16 KRISTEN OELSCHLAGER Officer 29,911 $618.0K 2026-06-16 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-06-01 Derek Maetzold Officer 14,008 $293.7K 2026-06-01 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-05-07 Derek Maetzold Officer 14,008 $269.5K 2026-05-07 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-03-26 Derek Maetzold Officer 18,180 $449.0K 2026-03-26 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-03-12 Tobin Juvenal Chief Commercial Officer 20,863 $528.3K 2026-03-12 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-03-11 Derek Maetzold Officer 94,204 $2.46M 2026-03-11 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-03-05 FRANKLIN STOKES Officer 6,001 $169.0K 2026-03-05 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-03-05 GORDON B. COLE Director 7,403 $210.7K 2026-03-05 Morgan Stanley Smith Barney LLC … EDGAR
2026-03-03 FRANKLIN STOKES Officer 7,000 $195.9K 2026-03-03 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-01-05 Derek Maetzold Officer 12,051 $470.0K 2026-01-05 Goldman Sachs & Co. LLC 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio1.5
P/S Ratio2.0
EV/EBITDA-35.0
TTM Revenue$0.3B
TTM Net Income$-0.0B
TTM EPS$-0.43
ROE-2.8%
Debt/Equity0.02